Dynavax Technologies Corporation's Series B Round

Dynavax Technologies Corporation raised a round of funding on July 23, 1998.

Dynavax Technologies Corporation discovers, develops, and intends to commercialize innovative TLR9 agonist-based products to treat and prevent infectious diseases, allergies, cancer, and chronic infla…

Articles about Dynavax Technologies Corporation's Series B Round: